Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.

Circulation. Genomic and precision medicine - 1 Apr 2018

van Velzen Hannah G, Schinkel Arend F L, Baart Sara J, Oldenburg Rogier A, Frohn-Mulder Ingrid M E, van Slegtenhorst Marjon A, Michels Michelle

Abstract excerpt

BACKGROUND: Contemporary hypertrophic cardiomyopathy (HCM) family screening includes clinical evaluation and genetic testing (GT). This screening strategy requires the identification of a pathogenic mutation in the proband. Our aim was to examine the results of this HCM screening strategy. METHODS: Between 1985 and 2016, 777 relatives of 209 probands were assessed in the context of HCM screening....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy, Hypertrophic, Familial
Share to Family

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Genetic Markers

Share to Genetic Testing

Share to Heredity

Share to Predictive Value of Tests

Share to Risk Assessment

Source

Identifiers

PMID: 29661763
DOI: 10.1161/CIRCGEN.117.001896

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.PMID 29661763Read ↗

Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup.Semantic proximity Read ↗

Family screening for hypertrophic cardiomyopathy: initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individualsSemantic proximity Read ↗

Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.Semantic proximity Read ↗

Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.Semantic proximity Read ↗

Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathySemantic proximity Read ↗

ESC EORP Cardiomyopathy Registry: Real-Life Practice of Genetic Counselling and Testing in Adult Cardiomyopathy PatientsSemantic proximity Read ↗

Family screening in hypertrophic cardiomyopathy is underperformed, but can be improved by a specialised clinic.Semantic proximity Read ↗

Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Hypertrophic Cardiomyopathy – The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family ScreeningSemantic proximity Read ↗

Genetic, Clinical, and Sociodemographic Profile in Individuals with Diagnosis or Family History of Hypertrophic Cardiomyopathy: Insights from a Prospective CohortSemantic proximity Read ↗

Hypertrophic Cardiomyopathy: The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family Screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.